Table 2.
Lab results before starting continuous venovenous hemodiafiltration (medians and interquartile ranges, IQR).
Liver failure | p-value | |||
---|---|---|---|---|
Yes (62) | No (138) | Total (200) | ||
Creatinine (mg/dl) | 2.7 (1.8–3.5) | 2.7 (1.9–3.7) | 2.7 (1.91–3.71) | 0.579 |
Urea (mg/dl) | 99 (61–148) | 114 (84–153) | 112 (78–151) | 0.119 |
Basal sodium (mEq/l) | 139 (134–142) | 139 (135–143) | 139 (135–143) | 0.968 |
Basal potassium (mEq/l) | 4.4 (4.0–5.0) | 4.3 (3.8–5.0) | 4.3 (3.9–5.0) | 0.3125 |
Chloride (mEq/l) | 105 (100–108) | 104 (99–110) | 104 (99–108) | 0.736 |
Anion gap | 18 (14–26) | 16 (12–19) | 16 (13–21) | 0.196 |
Systemic ionized calcium (mmol/l) | 1.06 (1.02–1.14) | 1.10 (1.06–1.16) | 1.10 (1.04–1.15) | 0.019 |
Total calcium (mg/dl) | 8.4 (7.7–8.9) | 8.2 (7.8–8.7) | 8.2 (7.9–8.8) | 0.920 |
Phosphor (mg/dl) | 5.7 (4.3–6.7) | 4.7 (3.7–6.5) | 4.7 (3.8–6.6) | 0.252 |
Magnesium (mg/dl) | 1.6 (1.4–2.0) | 1.6 (1.4–1.8) | 1.6 (1.4–1.88) | 0.615 |
pH | 7.32 (7.26–7.38) | 7.37 (7.29–7.43) | 7.35 (7.27–7.41) | 0.011 |
Bicarbonate (mEq/l) | 15.9 (12.7–20.5) | 19.4 (16.8–23.2) | 18.6 (15.2–22.1) | < 0.001 |
Lactate (mg/dl) | 33.5 (17.8–83) | 16.0 (12–26) | 19 (13–35) | < 0.001 |
AST (U/l) | 203 (51–3180) | 70 (30–241) | 79 (36–482) | 0.03 |
ALT (U/l) | 282 (42–2658) | 49 (31–115) | 62 (34–308) | 0.01 |
Total bilirubin (mg/dl) | 7.7 (4.7–11.2) | 1.3 (0.6–4.7) | 2.9 (0.9–7.8) | < 0.001 |
Direct bilirubin (mg/dL) | 4.8 (2.9–8.2) | 0.9 (0.4–3.0) | 2.1 (0.7–5.4) | < 0.001 |
INR | 2.68 (2.24–3.63) | 1.42 (1.27–1.73) | 1.7 (1.33–2.37) | < 0.001 |
APPT ratio | 1.72 (1.54–2.1) | 1.28 (1.13–1.59) | 1.44 (1.19–1.75) | < 0.001 |
Hemoglobin (g/dl) | 8.1 (7.1–9.3) | 9.1 (8.1–10.5) | 8.9 (7.8–10.1) | < 0.001 |
Hematocrit (%) | 23.1 (21.1–28.2) | 27.1 (23.9–30.7) | 26.3 (22.1–30) | < 0.001 |
Platelets × 103 (n/µl) | 51.5 (35.8–51.5) | 109 (48–179) | 77 (42–155) | < 0.001 |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; INR, international normalized ratio; APPT, activated partial thromboplastin time.